drugset / Trial / NCT01296607

Effects of Urocortins on Forearm Arterial Blood Flow in Healthy Volunteers - Protocol 4

NCT01296607

RandomizedCrossoverDouble-blindBasic science

Summary

Impairment of the heart's pumping capacity (heart failure) remains a major clinical problem with a poor prognosis and the search for novel treatments remains an important area of research. Urocortins are proteins that appear to increase blood flow and heart pumping activity. There has been particular interest in the role of Urocortins 2 \& 3 (subtypes of Urocortins) in heart failure. In this study, we will examine the pharmacokinetics and pharmacodynamics (in particular the onset-offset of action and reproducibility of vasodilator effects) of Urocortins 2 \& 3 on forearm arterial blood flow healthy volunteers. Utilising the well-established technique of 'forearm venous occlusion plethysmography', we will be able to focus on the local effects of urocortins on arterial blood flow in forearm vessels, without affecting this system in the body as a whole.

Timeline

Start
2011-02
Primary completion
2011-06
Completion
2011-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Urocortin 2 Protein / enzyme biologic 15 ng Other
Subject Urocortin 2 Protein / enzyme biologic 50 ng Other
Subject Urocortin 2 Protein / enzyme biologic 150 ng Other
Subject Urocortin 2 Protein / enzyme biologic 498 ng Other
Subject Urocortin 3 Protein / enzyme biologic 5 ug Other
Subject Urocortin 3 Protein / enzyme biologic 15 ug Other
Subject Urocortin 3 Protein / enzyme biologic 50 ug Other
Subject Urocortin 3 Protein / enzyme biologic 150 ug Other

Indications